SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
January 4th, 2022 | 🕒
iSpeech TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on
Gloss